Myoung-Don Oh to Antiviral Agents
This is a "connection" page, showing publications Myoung-Don Oh has written about Antiviral Agents.
Connection Strength
0.165
-
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. J Korean Med Sci. 2020 Jun 22; 35(24):e231.
Score: 0.082
-
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021 03 04; 384(9):795-807.
Score: 0.021
-
Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 11 05; 383(19):1813-1826.
Score: 0.021
-
Compassionate use of hzVSF-v13 in two patients with severe COVID-19. J Med Virol. 2020 11; 92(11):2371-2373.
Score: 0.020
-
Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med. 2018 03; 33(2):233-246.
Score: 0.017
-
Pandemic response lessons from influenza H1N1 2009 in Asia. Respirology. 2011 Aug; 16(6):876-82.
Score: 0.003